FAMILY WELLNESS CLOTRIMAZOLE

FAMILY WELLNESS CLOTRIMAZOLE was reported 11722 times

FAMILY WELLNESS CLOTRIMAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOANEURYSM INFECTION 41 0.7736
1 VAGINAL FLATULENCE 172 0.5677
2 PULMONARY VASCULITIS 183 0.3401
3 TOTAL LUNG CAPACITY ABNORMAL 120 0.3085
4 CAPILLARITIS 70 0.2536
5 SPIROMETRY ABNORMAL 117 0.1957
6 VASCULAR PSEUDOANEURYSM RUPTURED 45 0.1940
7 GRAFT ISCHAEMIA 9 0.1915
8 MITE ALLERGY 122 0.1863
9 PERSISTENT GENITAL AROUSAL DISORDER 40 0.1724
10 HYPOXIC ISCHAEMIC ENCEPHALOPATHY NEONATAL 9 0.1607
11 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 105 0.1432
12 MYCOTIC ALLERGY 121 0.1415
13 DUST ALLERGY 123 0.1254
14 SCHIZOAFFECTIVE DISORDER 216 0.1210
15 NEURITIS 183 0.1184
16 FEMALE GENITAL TRACT FISTULA 181 0.1059
17 SINUS RHYTHM 45 0.1032
18 PURPURA SENILE 12 0.0984
19 CONJUNCTIVITIS ALLERGIC 123 0.0830
20 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 164 0.0804
21 RADICULOPATHY 180 0.0682
22 MACULAR DEGENERATION 812 0.0679
23 CHRONIC SINUSITIS 248 0.0660
24 PROCTITIS 174 0.0621
25 RESPIRATORY SYMPTOM 176 0.0618
26 GENITAL CANDIDIASIS 11 0.0516
27 TARSAL TUNNEL SYNDROME 11 0.0500
28 CONGENITAL TRICUSPID VALVE INCOMPETENCE 9 0.0450
29 FORCED EXPIRATORY VOLUME DECREASED 122 0.0430
30 NORMOCHROMIC NORMOCYTIC ANAEMIA 126 0.0419
31 FEMALE REPRODUCTIVE TRACT DISORDER 9 0.0413
32 TOXIC SHOCK SYNDROME 25 0.0397
33 RETROPERITONEAL ABSCESS 12 0.0380
34 PULMONARY ALVEOLAR HAEMORRHAGE 188 0.0335
35 ENDOCRINE OPHTHALMOPATHY 29 0.0334
36 NEUROLOGICAL SYMPTOM 182 0.0318
37 TENOSYNOVITIS STENOSANS 17 0.0305
38 EYE INFECTION TOXOPLASMAL 11 0.0277
39 VULVOVAGINAL CANDIDIASIS 37 0.0273
40 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 28 0.0264
41 ARTERIAL HAEMORRHAGE 30 0.0262
42 CLEFT PALATE 42 0.0217
43 ARTERIOSCLEROSIS CORONARY ARTERY 143 0.0216
44 ORAL CANDIDIASIS 265 0.0201
45 HYPERPARATHYROIDISM SECONDARY 49 0.0195
46 VAGINAL DISCHARGE 195 0.0193
47 NEPHROGENIC ANAEMIA 87 0.0188
48 RENAL ISCHAEMIA 10 0.0183
49 INFECTIVE ANEURYSM 9 0.0182
50 VASCULITIS 199 0.0171
51 PARAESTHESIA ORAL 240 0.0166
52 OBSTRUCTIVE AIRWAYS DISORDER 185 0.0166
53 MEAN CELL HAEMOGLOBIN INCREASED 27 0.0163
54 TUMOUR FLARE 11 0.0161
55 FULL BLOOD COUNT ABNORMAL 170 0.0161
56 BONE DEMINERALISATION 17 0.0161
57 NASAL ULCER 25 0.0157
58 RESORPTION BONE INCREASED 12 0.0146
59 VANISHING BILE DUCT SYNDROME 16 0.0143
60 ARTERIOSCLEROSIS 134 0.0142
61 PERINEAL PAIN 10 0.0140
62 DRUG LEVEL INCREASED 231 0.0139
63 VULVOVAGINAL ERYTHEMA 11 0.0132
64 ARTHRODESIS 13 0.0128
65 NEONATAL ASPHYXIA 9 0.0127
66 BLISTER RUPTURE 9 0.0121
67 DISTURBANCE IN SEXUAL AROUSAL 11 0.0120
68 WOUND COMPLICATION 41 0.0119
69 CANDIDA INFECTION 201 0.0119
70 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 29 0.0109
71 PULMONARY FIBROSIS 202 0.0105
72 EYELID DISORDER 24 0.0104
73 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 175 0.0103
74 NODULE 133 0.0102
75 HEART TRANSPLANT REJECTION 10 0.0096
76 HYPOTONIA NEONATAL 15 0.0096
77 REBOUND ACID HYPERSECRETION 28 0.0092
78 VESTIBULAR DISORDER 11 0.0090
79 PULMONARY VALVE INCOMPETENCE 13 0.0089
80 AUTONOMIC NEUROPATHY 9 0.0089
81 LYMPHADENITIS 20 0.0083
82 GENITAL PAIN 12 0.0081
83 PROCEDURAL PAIN 219 0.0079
84 LIP HAEMORRHAGE 10 0.0078
85 CANDIDIASIS 31 0.0077
86 GENITAL RASH 11 0.0077
87 END STAGE RENAL DISEASE 140 0.0077
88 DYSLIPIDAEMIA 38 0.0075
89 VERTIGO POSITIONAL 13 0.0074
90 APLASTIC ANAEMIA 38 0.0073
91 FREQUENT BOWEL MOVEMENTS 195 0.0072
92 HAEMOPTYSIS 195 0.0070
93 ELECTROCARDIOGRAM QT PROLONGED 239 0.0066
94 HYPOTHYROIDISM 205 0.0064
95 SHOCK HAEMORRHAGIC 52 0.0064
96 ESCHERICHIA BACTERAEMIA 15 0.0064
97 RETROPERITONEAL HAEMATOMA 14 0.0063
98 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 444 0.0062
99 HYPOGLYCAEMIA NEONATAL 10 0.0062
100 SYNOVIAL CYST 28 0.0061
101 SWELLING OF EYELID 38 0.0060
102 RECTAL HAEMORRHAGE 256 0.0060
103 VAGINAL INFECTION 27 0.0057
104 INFUSION SITE DISCHARGE 10 0.0057
105 TINEA PEDIS 9 0.0056
106 THROMBOPHLEBITIS SUPERFICIAL 17 0.0056
107 SWOLLEN TONGUE 173 0.0055
108 COLITIS 209 0.0055
109 VENTRICULAR DYSFUNCTION 14 0.0054
110 HYPOXIA 187 0.0053
111 FUNGAL SKIN INFECTION 21 0.0052
112 CHRONIC KIDNEY DISEASE 395 0.0052
113 SPLENIC INFARCTION 9 0.0052
114 CLOSTRIDIUM TEST POSITIVE 11 0.0050
115 TEMPERATURE REGULATION DISORDER 11 0.0049
116 TONGUE BLISTERING 11 0.0049
117 VULVOVAGINAL BURNING SENSATION 30 0.0049
118 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0049
119 SUBCUTANEOUS ABSCESS 23 0.0048
120 VULVOVAGINAL PAIN 23 0.0048
121 GINGIVAL SWELLING 21 0.0048
122 VULVOVAGINAL PRURITUS 24 0.0047
123 RENAL TUBULAR ACIDOSIS 10 0.0046
124 ECONOMIC PROBLEM 69 0.0045
125 VULVOVAGINAL DISCOMFORT 20 0.0045
126 OLIGOHYDRAMNIOS 15 0.0045
127 HAEMATOCHEZIA 247 0.0045
128 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 213 0.0044
129 LEFT VENTRICULAR FAILURE 15 0.0044
130 HYPOSPADIAS 9 0.0043
131 ABDOMINAL ABSCESS 19 0.0043
132 COLITIS ULCERATIVE 190 0.0042
133 PRURITUS GENITAL 10 0.0042
134 WHEEZING 249 0.0042
135 ANHEDONIA 110 0.0042
136 LUNG DISORDER 205 0.0042
137 RALES 24 0.0041
138 WOUND SECRETION 16 0.0041
139 NEUTROPENIC SEPSIS 29 0.0041
140 HYPERCHOLESTEROLAEMIA 39 0.0040
141 BLOOD PRESSURE DIASTOLIC ABNORMAL 10 0.0039
142 DYSAESTHESIA 12 0.0039
143 CYTOMEGALOVIRUS COLITIS 9 0.0039
144 EYE INFECTION 44 0.0039
145 INFUSION RELATED REACTION 258 0.0039
146 BLOOD CHLORIDE DECREASED 10 0.0039
147 PANCREATIC CARCINOMA METASTATIC 11 0.0039
148 EXFOLIATIVE RASH 10 0.0038
149 ADENOVIRUS INFECTION 11 0.0038
150 KIDNEY TRANSPLANT REJECTION 18 0.0037
151 TRANSPLANT REJECTION 30 0.0037
152 VITAMIN D DECREASED 32 0.0037
153 PREMATURE RUPTURE OF MEMBRANES 9 0.0037
154 THERAPEUTIC PRODUCT EFFECT DELAYED 17 0.0037
155 PRODUCTIVE COUGH 174 0.0036
156 FOOT DEFORMITY 40 0.0036
157 TRICUSPID VALVE INCOMPETENCE 28 0.0035
158 CANCER PAIN 9 0.0035
159 OSTEOPENIA 53 0.0035
160 LIP PAIN 10 0.0035
161 SKIN INFECTION 39 0.0035
162 DYSPEPSIA 338 0.0034
163 ESCHERICHIA INFECTION 28 0.0034
164 SKIN LACERATION 37 0.0034
165 GLOSSITIS 12 0.0034
166 RENAL TUBULAR NECROSIS 33 0.0034
167 TUBULOINTERSTITIAL NEPHRITIS 63 0.0034
168 INFUSION SITE HAEMORRHAGE 11 0.0033
169 ATELECTASIS 32 0.0033
170 NEPHROGENIC SYSTEMIC FIBROSIS 10 0.0033
171 VASCULAR DEVICE INFECTION 15 0.0033
172 VULVOVAGINAL MYCOTIC INFECTION 13 0.0033
173 ORAL FUNGAL INFECTION 9 0.0033
174 UROSEPSIS 30 0.0032
175 FUNGAL INFECTION 107 0.0032
176 CYTOMEGALOVIRUS VIRAEMIA 14 0.0031
177 CUSHINGOID 10 0.0031
178 INFUSION SITE SWELLING 19 0.0030
179 OESOPHAGEAL CANDIDIASIS 12 0.0030
180 PLANTAR FASCIITIS 10 0.0030
181 FREEZING PHENOMENON 11 0.0030
182 SKIN ABRASION 14 0.0030
183 MASTICATION DISORDER 9 0.0029
184 PERIPHERAL VENOUS DISEASE 12 0.0029
185 PARANASAL SINUS DISCOMFORT 11 0.0029
186 FACE INJURY 11 0.0029
187 MYOPATHY 25 0.0029
188 COMMUNICATION DISORDER 11 0.0029
189 INFUSION SITE PAIN 37 0.0029
190 NECROTISING FASCIITIS 10 0.0028
191 TONGUE DISCOMFORT 12 0.0028
192 RHINOVIRUS INFECTION 11 0.0028
193 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
194 SMALL FOR DATES BABY 14 0.0028
195 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
196 ACUTE KIDNEY INJURY 428 0.0028
197 VAGINAL HAEMORRHAGE 121 0.0028
198 ANGIOEDEMA 123 0.0028
199 PATENT DUCTUS ARTERIOSUS 11 0.0028
200 RENAL TRANSPLANT 10 0.0028
201 OEDEMA MOUTH 9 0.0028
202 SPINAL OSTEOARTHRITIS 24 0.0027
203 CARPAL TUNNEL SYNDROME 38 0.0027
204 BACTERAEMIA 32 0.0027
205 HYPERACUSIS 10 0.0027
206 SWELLING FACE 174 0.0027
207 VITAMIN D DEFICIENCY 26 0.0027
208 CLOSTRIDIAL INFECTION 9 0.0027
209 CARDIAC MURMUR 23 0.0027
210 RENAL INJURY 78 0.0026
211 ASTHMA 294 0.0026
212 RENAL FAILURE CHRONIC 20 0.0026
213 ORAL PAIN 58 0.0026
214 ABSCESS LIMB 11 0.0026
215 FAECES HARD 10 0.0026
216 DERMATITIS CONTACT 29 0.0025
217 TONGUE DISCOLOURATION 11 0.0025
218 SKIN ULCER 65 0.0025
219 RENAL FAILURE 333 0.0025
220 ONYCHOMYCOSIS 11 0.0025
221 PROCTALGIA 16 0.0025
222 ENTEROCOCCAL INFECTION 12 0.0025
223 DYSPHONIA 145 0.0025
224 MITRAL VALVE INCOMPETENCE 28 0.0025
225 FLANK PAIN 23 0.0025
226 SPINAL COMPRESSION FRACTURE 20 0.0024
227 SOCIAL PROBLEM 10 0.0024
228 BUNDLE BRANCH BLOCK RIGHT 11 0.0024
229 BLOOD PRESSURE DIASTOLIC INCREASED 11 0.0024
230 HAEMODIALYSIS 20 0.0024
231 MOUTH ULCERATION 50 0.0024
232 CELLULITIS 119 0.0024
233 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
234 ECCHYMOSIS 16 0.0023
235 TENDERNESS 24 0.0023
236 THROMBOSIS 185 0.0023
237 MELANOCYTIC NAEVUS 10 0.0023
238 CONJUNCTIVITIS 42 0.0023
239 SEASONAL ALLERGY 32 0.0023
240 PELVIC PAIN 41 0.0023
241 AZOTAEMIA 9 0.0023
242 TRIGEMINAL NEURALGIA 9 0.0022
243 DRUG INTERACTION 355 0.0022
244 VITAMIN B12 DEFICIENCY 9 0.0022
245 DIABETIC NEUROPATHY 11 0.0022
246 MATERNAL DRUGS AFFECTING FOETUS 17 0.0022
247 MUCOSAL INFLAMMATION 58 0.0022
248 URINARY INCONTINENCE 65 0.0022
249 SECRETION DISCHARGE 27 0.0022
250 FEBRILE NEUTROPENIA 143 0.0022
251 HAEMORRHOIDS 42 0.0022
252 PHLEBITIS 11 0.0021
253 NEPHROPATHY 20 0.0021
254 HYDRONEPHROSIS 16 0.0021
255 PAPULE 15 0.0021
256 INTERVERTEBRAL DISC DISORDER 9 0.0021
257 PURULENT DISCHARGE 9 0.0021
258 GESTATIONAL DIABETES 10 0.0021
259 PULMONARY EMBOLISM 198 0.0021
260 FEEDING DISORDER 42 0.0021
261 COMPRESSION FRACTURE 11 0.0021
262 GRIP STRENGTH DECREASED 18 0.0020
263 VENOOCCLUSIVE LIVER DISEASE 10 0.0020
264 UPPER GASTROINTESTINAL HAEMORRHAGE 34 0.0020
265 INFUSION SITE ERYTHEMA 17 0.0020
266 CHOKING SENSATION 11 0.0020
267 IMPAIRED GASTRIC EMPTYING 27 0.0020
268 ANAEMIA 375 0.0020
269 ISCHAEMIA 9 0.0020
270 OSTEOARTHRITIS 83 0.0020
271 EAR PAIN 38 0.0020
272 IMPAIRED QUALITY OF LIFE 28 0.0019
273 PHARYNGITIS STREPTOCOCCAL 21 0.0019
274 APHTHOUS ULCER 15 0.0019
275 INFUSION SITE EXTRAVASATION 12 0.0019
276 TOXIC EPIDERMAL NECROLYSIS 29 0.0019
277 ORTHOSTATIC HYPOTENSION 33 0.0019
278 SLEEP APNOEA SYNDROME 36 0.0019
279 PSEUDOMONAS INFECTION 16 0.0019
280 EXOSTOSIS 17 0.0019
281 DEFAECATION URGENCY 13 0.0019
282 CHEILITIS 10 0.0018
283 POOR VENOUS ACCESS 19 0.0018
284 HYDROCEPHALUS 10 0.0018
285 ASPERGILLUS INFECTION 12 0.0018
286 SLEEP DISORDER 128 0.0018
287 HYPERKERATOSIS 10 0.0018
288 CYSTIC FIBROSIS 10 0.0018
289 STEVENS-JOHNSON SYNDROME 40 0.0018
290 DERMATITIS BULLOUS 13 0.0018
291 HEART RATE ABNORMAL 10 0.0018
292 ATRIAL SEPTAL DEFECT 15 0.0018
293 MENISCUS INJURY 11 0.0018
294 FLUID OVERLOAD 26 0.0018
295 MULTIPLE ALLERGIES 14 0.0018
296 HIATUS HERNIA 23 0.0018
297 SCOLIOSIS 11 0.0018
298 SYNOVITIS 32 0.0018
299 SUBARACHNOID HAEMORRHAGE 18 0.0018
300 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
301 CARDIOMYOPATHY 26 0.0018
302 FEMORAL NECK FRACTURE 9 0.0018
303 ARTHROPOD BITE 13 0.0018
304 DERMATITIS ALLERGIC 22 0.0017
305 MULTIPLE INJURIES 11 0.0017
306 MUSCULOSKELETAL CHEST PAIN 27 0.0017
307 PYELONEPHRITIS 15 0.0017
308 NOCTURIA 21 0.0017
309 BONE DENSITY DECREASED 54 0.0017
310 CONSTIPATION 375 0.0017
311 DERMATITIS 36 0.0017
312 CAESAREAN SECTION 20 0.0017
313 DENTAL CARIES 19 0.0017
314 BLOOD CHOLESTEROL INCREASED 80 0.0017
315 INCONTINENCE 18 0.0017
316 OSTEOPOROSIS 70 0.0017
317 ABDOMINAL PAIN 395 0.0017
318 RASH PRURITIC 92 0.0017
319 FACIAL PAIN 15 0.0017
320 ERYTHEMA 345 0.0017
321 ODYNOPHAGIA 10 0.0017
322 ACCIDENT 20 0.0017
323 HYPOALBUMINAEMIA 13 0.0017
324 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
325 GINGIVITIS 9 0.0017
326 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 87 0.0017
327 ENDOPHTHALMITIS 10 0.0017
328 WEIGHT DECREASED 465 0.0017
329 GLAUCOMA 32 0.0017
330 EAR DISCOMFORT 17 0.0017
331 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9 0.0017
332 NEOPLASM 19 0.0017
333 ANXIETY 470 0.0016
334 URINARY RETENTION 55 0.0016
335 TEMPERATURE INTOLERANCE 17 0.0016
336 PATHOGEN RESISTANCE 15 0.0016
337 LYMPHOCYTE COUNT DECREASED 29 0.0016
338 RENAL CYST 13 0.0016
339 BRONCHITIS 121 0.0016
340 SKIN HYPERPIGMENTATION 14 0.0016
341 CARDIOMEGALY 20 0.0016
342 HYPOPHOSPHATAEMIA 12 0.0016
343 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 89 0.0016
344 RHINITIS 13 0.0016
345 MALNUTRITION 18 0.0016
346 JOINT STIFFNESS 42 0.0016
347 STOMATITIS 97 0.0016
348 LYMPHOEDEMA 11 0.0016
349 URINARY TRACT INFECTION 271 0.0016
350 FOETAL EXPOSURE DURING PREGNANCY 129 0.0016
351 LUNG INFILTRATION 14 0.0016
352 BLISTER 89 0.0016
353 CARDIAC VALVE DISEASE 9 0.0016
354 ACIDOSIS 12 0.0016
355 OBESITY 25 0.0016
356 SKIN EXFOLIATION 132 0.0016
357 BIPOLAR DISORDER 17 0.0016
358 DRUG INTOLERANCE 151 0.0016
359 OESOPHAGITIS 17 0.0016
360 GASTROOESOPHAGEAL REFLUX DISEASE 125 0.0016
361 SINUS TACHYCARDIA 22 0.0015
362 DYSURIA 57 0.0015
363 DIVERTICULUM 11 0.0015
364 STAPHYLOCOCCAL INFECTION 51 0.0015
365 C-REACTIVE PROTEIN INCREASED 56 0.0015
366 TRANSFUSION 16 0.0015
367 PYREXIA 528 0.0015
368 BRADYKINESIA 9 0.0015
369 WALKING AID USER 10 0.0015
370 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
371 BLADDER DISORDER 15 0.0015
372 GOUT 27 0.0015
373 ORAL DISORDER 11 0.0015
374 SKIN DISORDER 50 0.0015
375 BODY HEIGHT DECREASED 16 0.0015
376 CONTUSION 144 0.0015
377 PHARYNGEAL OEDEMA 23 0.0015
378 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
379 OSTEOMYELITIS 27 0.0015
380 SCAB 17 0.0015
381 ABORTION INDUCED 14 0.0015
382 DIALYSIS 21 0.0015
383 PRURITUS GENERALISED 32 0.0015
384 DECUBITUS ULCER 12 0.0015
385 DRUG EXPOSURE DURING PREGNANCY 50 0.0015
386 CONDITION AGGRAVATED 445 0.0015
387 BONE LOSS 22 0.0015
388 WOUND INFECTION 16 0.0015
389 HYPERGLYCAEMIA 53 0.0015
390 DROOLING 10 0.0014
391 HYPOKINESIA 21 0.0014
392 ORAL DISCOMFORT 20 0.0014
393 GASTROENTERITIS 21 0.0014
394 HYPOMAGNESAEMIA 20 0.0014
395 GAIT INABILITY 48 0.0014
396 PNEUMONITIS 39 0.0014
397 HYPERSOMNIA 41 0.0014
398 HYPERSENSITIVITY 265 0.0014
399 HYPERLIPIDAEMIA 17 0.0014
400 CHROMATURIA 32 0.0014
401 HAND FRACTURE 10 0.0014
402 IRON DEFICIENCY ANAEMIA 13 0.0014
403 HYPOKALAEMIA 65 0.0014
404 UPPER RESPIRATORY TRACT INFECTION 65 0.0014
405 PRODUCT DISTRIBUTION ISSUE 13 0.0014
406 AFFECTIVE DISORDER 11 0.0014
407 PRESYNCOPE 34 0.0014
408 PULMONARY HYPERTENSION 29 0.0014
409 DECREASED ACTIVITY 15 0.0014
410 BLOOD ALBUMIN DECREASED 11 0.0014
411 RASH ERYTHEMATOUS 66 0.0014
412 PLEURAL EFFUSION 84 0.0014
413 TASTE DISORDER 28 0.0014
414 PANCYTOPENIA 77 0.0014
415 RESTLESS LEGS SYNDROME 25 0.0014
416 BLOOD UREA INCREASED 23 0.0014
417 BONE DISORDER 25 0.0014
418 HEART RATE IRREGULAR 31 0.0014
419 BLOOD BILIRUBIN INCREASED 37 0.0014
420 THROAT TIGHTNESS 37 0.0014
421 PAIN IN EXTREMITY 403 0.0014
422 TOOTH INFECTION 18 0.0014
423 LOCALISED INFECTION 33 0.0014
424 ANGINA PECTORIS 39 0.0014
425 ANKLE FRACTURE 21 0.0014
426 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
427 QUALITY OF LIFE DECREASED 18 0.0013
428 MUSCLE RIGIDITY 16 0.0013
429 NIGHT SWEATS 43 0.0013
430 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
431 PHOTOPHOBIA 25 0.0013
432 PHARYNGEAL SWELLING 13 0.0013
433 PEMPHIGOID 10 0.0013
434 RENAL FAILURE ACUTE 56 0.0013
435 BURSITIS 16 0.0013
436 BLOOD CREATININE INCREASED 86 0.0013
437 SEPTIC SHOCK 57 0.0013
438 RESPIRATORY DISTRESS 36 0.0013
439 THROMBOCYTOPENIA 145 0.0013
440 MENTAL STATUS CHANGES 36 0.0013
441 OEDEMA PERIPHERAL 158 0.0013
442 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
443 FAECES DISCOLOURED 28 0.0013
444 LIP SWELLING 43 0.0013
445 IMMUNE SYSTEM DISORDER 17 0.0013
446 PULMONARY CONGESTION 17 0.0013
447 CYST 16 0.0013
448 EMPHYSEMA 13 0.0013
449 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
450 CYSTITIS 41 0.0013
451 SCAR 22 0.0013
452 DYSPNOEA 726 0.0013
453 DEEP VEIN THROMBOSIS 83 0.0013
454 TOOTH ABSCESS 13 0.0013
455 LACERATION 12 0.0013
456 NEURALGIA 31 0.0013
457 TORSADE DE POINTES 10 0.0013
458 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
459 BLOOD SODIUM DECREASED 24 0.0013
460 PAIN 782 0.0013
461 JOINT SWELLING 153 0.0013
462 FURUNCLE 10 0.0013
463 URINE OUTPUT DECREASED 11 0.0013
464 FLUID RETENTION 64 0.0013
465 SCIATICA 20 0.0013
466 NECK PAIN 70 0.0013
467 GRAFT VERSUS HOST DISEASE 9 0.0013
468 GLOSSODYNIA 28 0.0012
469 TUMOUR LYSIS SYNDROME 11 0.0012
470 SINUS BRADYCARDIA 12 0.0012
471 BURNING SENSATION 87 0.0012
472 EAR INFECTION 33 0.0012
473 INTERVERTEBRAL DISC PROTRUSION 27 0.0012
474 BACTERIAL INFECTION 23 0.0012
475 OROPHARYNGEAL PAIN 114 0.0012
476 SINUSITIS 126 0.0012
477 HYPERKALAEMIA 43 0.0012
478 EJECTION FRACTION DECREASED 19 0.0012
479 CORONARY ARTERY DISEASE 37 0.0012
480 ABNORMAL FAECES 10 0.0012
481 BLINDNESS TRANSIENT 9 0.0012
482 BASAL CELL CARCINOMA 19 0.0012
483 MULTIPLE FRACTURES 20 0.0012
484 LEUKOCYTOSIS 22 0.0012
485 POOR QUALITY SLEEP 26 0.0012
486 HEADACHE 754 0.0012
487 INCREASED TENDENCY TO BRUISE 11 0.0012
488 LIVE BIRTH 10 0.0012
489 MALIGNANT MELANOMA 16 0.0012
490 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
491 EMOTIONAL DISTRESS 143 0.0012
492 INSURANCE ISSUE 18 0.0012
493 ARTHRITIS 92 0.0012
494 FLATULENCE 66 0.0012
495 CONGENITAL ANOMALY 9 0.0012
496 FOOT FRACTURE 22 0.0012
497 HAEMATOCRIT DECREASED 23 0.0012
498 GASTRIC ULCER 22 0.0012
499 MULTI-ORGAN FAILURE 20 0.0012
500 PELVIC FRACTURE 9 0.0012
501 VENTRICULAR EXTRASYSTOLES 12 0.0012
502 ACUTE MYELOID LEUKAEMIA 18 0.0012
503 PETECHIAE 12 0.0011
504 EPISTAXIS 86 0.0011
505 MENTAL DISORDER 50 0.0011
506 DEAFNESS 30 0.0011
507 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
508 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
509 RASH MACULAR 40 0.0011
510 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
511 HAEMORRHAGE INTRACRANIAL 17 0.0011
512 NASAL DISCOMFORT 9 0.0011
513 DIZZINESS POSTURAL 11 0.0011
514 SEPSIS 126 0.0011
515 PHARYNGITIS 14 0.0011
516 ABSCESS 18 0.0011
517 TOOTH DISORDER 25 0.0011
518 ELECTROLYTE IMBALANCE 13 0.0011
519 RIB FRACTURE 23 0.0011
520 GASTROINTESTINAL INFECTION 10 0.0011
521 NEUROPATHY PERIPHERAL 106 0.0011
522 HOSPICE CARE 11 0.0011
523 RESPIRATORY TRACT INFECTION 29 0.0011
524 SINUS DISORDER 22 0.0011
525 TOOTH LOSS 23 0.0011
526 SEXUAL DYSFUNCTION 13 0.0011
527 POST PROCEDURAL INFECTION 9 0.0011
528 BACK PAIN 257 0.0011
529 LIMB INJURY 30 0.0011
530 MUSCULOSKELETAL DISCOMFORT 19 0.0011
531 OXYGEN SATURATION DECREASED 62 0.0011
532 POLLAKIURIA 46 0.0011
533 THYROID DISORDER 17 0.0011
534 MALAISE 483 0.0011
535 TENDONITIS 17 0.0011
536 RASH 478 0.0011
537 PRODUCT USE ISSUE 206 0.0011
538 DYSSTASIA 32 0.0011
539 LETHARGY 63 0.0011
540 PULMONARY OEDEMA 49 0.0011
541 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
542 ROTATOR CUFF SYNDROME 14 0.0011
543 PHOTOSENSITIVITY REACTION 18 0.0011
544 ACUTE MYOCARDIAL INFARCTION 32 0.0011
545 DIVERTICULITIS 30 0.0011
546 EATING DISORDER 23 0.0011
547 BODY TEMPERATURE INCREASED 22 0.0011
548 DIABETES MELLITUS 82 0.0011
549 RESPIRATORY FAILURE 78 0.0011
550 HYPONATRAEMIA 60 0.0011
551 GALLBLADDER DISORDER 19 0.0011
552 HEPATIC CIRRHOSIS 20 0.0011
553 DYSPHAGIA 101 0.0011
554 BLINDNESS UNILATERAL 15 0.0011
555 DYSPNOEA EXERTIONAL 40 0.0011
556 HYPOAESTHESIA ORAL 16 0.0011
557 PERIPHERAL SWELLING 163 0.0011
558 FACIAL PARALYSIS 9 0.0011
559 MICTURITION URGENCY 12 0.0010
560 GENERALISED OEDEMA 13 0.0010
561 DRUG INEFFECTIVE 1384 0.0010
562 FOLLICULITIS 11 0.0010
563 HAIR TEXTURE ABNORMAL 14 0.0010
564 PSYCHOLOGICAL TRAUMA 9 0.0010
565 NAUSEA 825 0.0010
566 PNEUMONIA ASPIRATION 26 0.0010
567 ACUTE RESPIRATORY FAILURE 20 0.0010
568 DEVICE RELATED INFECTION 16 0.0010
569 DRY MOUTH 84 0.0010
570 LOWER RESPIRATORY TRACT INFECTION 47 0.0010
571 PREMATURE BABY 31 0.0010
572 LUNG INFECTION 16 0.0010
573 TACHYPNOEA 14 0.0010
574 HAEMATEMESIS 26 0.0010
575 GINGIVAL BLEEDING 14 0.0010
576 METASTASES TO LIVER 18 0.0010
577 PAIN IN JAW 29 0.0010
578 HAEMOGLOBIN DECREASED 105 0.0010
579 HYPOTENSION 205 0.0010
580 VIRAL INFECTION 34 0.0010
581 RHINORRHOEA 66 0.0010
582 BRAIN FOG 16 0.0010
583 SKIN LESION 28 0.0010
584 ASCITES 30 0.0010
585 DRUG-INDUCED LIVER INJURY 32 0.0010
586 PSORIASIS 133 0.0010
587 HYPOPHAGIA 26 0.0010
588 LYMPHADENOPATHY 36 0.0010
589 PRODUCT USE COMPLAINT 16 0.0010
590 RED BLOOD CELL COUNT DECREASED 29 0.0010
591 RESPIRATORY RATE INCREASED 9 0.0010
592 SKIN HAEMORRHAGE 15 0.0010
593 ARTHROPATHY 56 0.0010
594 PULMONARY MASS 15 0.0010
595 ATRIAL FIBRILLATION 98 0.0010
596 NASAL CONGESTION 59 0.0010
597 APHONIA 14 0.0010
598 WRIST FRACTURE 12 0.0010
599 ANAL INCONTINENCE 9 0.0010
600 GASTROENTERITIS VIRAL 18 0.0010
601 CARDIAC FAILURE CONGESTIVE 80 0.0010
602 GASTRITIS 26 0.0010
603 PNEUMONIA 319 0.0010
604 DRUG LEVEL DECREASED 10 0.0010
605 INTERNATIONAL NORMALISED RATIO INCREASED 28 0.0010
606 ENCEPHALOPATHY 24 0.0010
607 OEDEMA 53 0.0010
608 MUSCULAR WEAKNESS 111 0.0010
609 CHOLELITHIASIS 32 0.0010
610 ORAL HERPES 19 0.0010
611 HELICOBACTER INFECTION 10 0.0010
612 HYPOGLYCAEMIA 47 0.0010
613 INFECTION 140 0.0010
614 RASH GENERALISED 25 0.0010
615 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
616 DEFORMITY 9 0.0010
617 DRY EYE 48 0.0010
618 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
619 PRURITUS 369 0.0010
620 THROAT IRRITATION 43 0.0010
621 DIARRHOEA 618 0.0010
622 BONE PAIN 56 0.0010
623 BLOOD PRESSURE ABNORMAL 19 0.0010
624 FALL 318 0.0010
625 SWELLING 89 0.0009
626 TYPE 2 DIABETES MELLITUS 32 0.0009
627 SPINAL DISORDER 9 0.0009
628 SPINAL FRACTURE 19 0.0009
629 CYTOKINE RELEASE SYNDROME 19 0.0009
630 INTENTIONAL DOSE OMISSION 27 0.0009
631 JOINT DISLOCATION 10 0.0009
632 EYE INFLAMMATION 9 0.0009
633 CATARACT 56 0.0009
634 SYNCOPE 94 0.0009
635 TOOTHACHE 17 0.0009
636 NEPHROLITHIASIS 43 0.0009
637 DEHYDRATION 125 0.0009
638 DYSKINESIA 38 0.0009
639 HAEMATURIA 32 0.0009
640 HEREDITARY ANGIOEDEMA 10 0.0009
641 HERNIA 18 0.0009
642 BLOOD IRON DECREASED 11 0.0009
643 THROMBOTIC MICROANGIOPATHY 9 0.0009
644 DECREASED APPETITE 214 0.0009
645 SKIN FISSURES 18 0.0009
646 LEUKOPENIA 46 0.0009
647 HAEMORRHAGE 96 0.0009
648 HEAD INJURY 29 0.0009
649 CONFUSIONAL STATE 148 0.0009
650 EYE SWELLING 34 0.0009
651 MYALGIA 155 0.0009
652 PSORIATIC ARTHROPATHY 37 0.0009
653 BRONCHOSPASM 13 0.0009
654 LIGAMENT SPRAIN 9 0.0009
655 ABDOMINAL PAIN LOWER 23 0.0009
656 COUGH 255 0.0009
657 PERICARDIAL EFFUSION 21 0.0009
658 TOOTH FRACTURE 10 0.0009
659 EYE PAIN 51 0.0009
660 TREMOR 150 0.0009
661 DYSARTHRIA 34 0.0009
662 MOVEMENT DISORDER 29 0.0009
663 DRUG ERUPTION 16 0.0009
664 DEPRESSION 205 0.0009
665 SALIVARY HYPERSECRETION 9 0.0009
666 ABDOMINAL PAIN UPPER 185 0.0009
667 BLOOD POTASSIUM DECREASED 27 0.0009
668 CARDIAC FAILURE 72 0.0009
669 DRUG RESISTANCE 23 0.0009
670 WOUND 25 0.0009
671 LIVER FUNCTION TEST ABNORMAL 26 0.0009
672 LACRIMATION INCREASED 27 0.0009
673 DELIRIUM 31 0.0009
674 JOINT INJURY 19 0.0009
675 HAEMATOMA 23 0.0009
676 HERPES ZOSTER 51 0.0009
677 IRRITABLE BOWEL SYNDROME 19 0.0009
678 ILEUS 11 0.0009
679 REBOUND EFFECT 10 0.0009
680 NEUTROPHIL COUNT DECREASED 36 0.0009
681 GASTROINTESTINAL DISORDER 79 0.0009
682 CHEST PAIN 163 0.0009
683 OFF LABEL USE 769 0.0009
684 COGNITIVE DISORDER 41 0.0009
685 EMOTIONAL DISORDER 27 0.0009
686 PRODUCT USE IN UNAPPROVED INDICATION 217 0.0009
687 MATERNAL EXPOSURE DURING PREGNANCY 78 0.0009
688 ABORTION SPONTANEOUS 35 0.0009
689 ILL-DEFINED DISORDER 53 0.0009
690 IMMUNODEFICIENCY 13 0.0009
691 RENAL IMPAIRMENT 73 0.0009
692 DISCOMFORT 53 0.0009
693 INJURY 61 0.0009
694 BLOOD POTASSIUM INCREASED 14 0.0009
695 APHASIA 26 0.0009
696 INFLUENZA 96 0.0009
697 ECZEMA 45 0.0009
698 HYPERTENSION 182 0.0009
699 MASS 12 0.0009
700 ABDOMINAL DISTENSION 89 0.0009
701 LYMPHOPENIA 12 0.0008
702 ASTHENIA 319 0.0008
703 FATIGUE 660 0.0008
704 WEIGHT INCREASED 189 0.0008
705 BREAST PAIN 9 0.0008
706 THIRST 15 0.0008
707 VOMITING 394 0.0008
708 PALPITATIONS 98 0.0008
709 BONE MARROW FAILURE 17 0.0008
710 THERAPY PARTIAL RESPONDER 13 0.0008
711 CHEST DISCOMFORT 85 0.0008
712 DIZZINESS 413 0.0008
713 SCHIZOPHRENIA 10 0.0008
714 IMPAIRED HEALING 27 0.0008
715 MUSCULOSKELETAL PAIN 43 0.0008
716 SOMNOLENCE 165 0.0008
717 ULCER 13 0.0008
718 CYTOPENIA 10 0.0008
719 RENAL DISORDER 38 0.0008
720 ILLNESS 84 0.0008
721 KIDNEY INFECTION 16 0.0008
722 CHILLS 95 0.0008
723 MEDICATION ERROR 45 0.0008
724 NERVE INJURY 9 0.0008
725 RASH MACULO-PAPULAR 18 0.0008
726 DISABILITY 16 0.0008
727 MIGRAINE 77 0.0008
728 TINNITUS 37 0.0008
729 HEPATIC STEATOSIS 15 0.0008
730 HALLUCINATION, VISUAL 17 0.0008
731 ABDOMINAL DISCOMFORT 135 0.0008
732 HAIR COLOUR CHANGES 10 0.0008
733 INSOMNIA 214 0.0008
734 LOCAL SWELLING 14 0.0008
735 SNEEZING 18 0.0008
736 NEPHROPATHY TOXIC 9 0.0008
737 CRYING 29 0.0008
738 BLOOD PRESSURE INCREASED 122 0.0008
739 INTESTINAL OBSTRUCTION 30 0.0008
740 PANIC ATTACK 29 0.0008
741 HYPOCALCAEMIA 15 0.0008
742 EXPOSURE DURING PREGNANCY 49 0.0008
743 VENTRICULAR TACHYCARDIA 13 0.0008
744 HEPATITIS 20 0.0008
745 LIMB DISCOMFORT 24 0.0008
746 BALANCE DISORDER 67 0.0008
747 APPLICATION SITE PAIN 17 0.0008
748 TRANSIENT ISCHAEMIC ATTACK 26 0.0008
749 PLASMA CELL MYELOMA 30 0.0008
750 SUBDURAL HAEMATOMA 11 0.0008
751 MUSCLE SPASMS 141 0.0008
752 OSTEONECROSIS OF JAW 19 0.0008
753 RHABDOMYOLYSIS 32 0.0008
754 PLATELET COUNT INCREASED 10 0.0008
755 HYPOACUSIS 33 0.0008
756 MOBILITY DECREASED 55 0.0008
757 CIRCULATORY COLLAPSE 13 0.0008
758 GAIT DISTURBANCE 146 0.0008
759 METRORRHAGIA 13 0.0008
760 AGEUSIA 19 0.0008
761 OCULAR HYPERAEMIA 36 0.0008
762 PANCREATITIS ACUTE 17 0.0008
763 RESPIRATORY TRACT CONGESTION 12 0.0008
764 PREMATURE DELIVERY 12 0.0008
765 MIDDLE INSOMNIA 14 0.0007
766 SENSORY DISTURBANCE 12 0.0007
767 FIBROMYALGIA 18 0.0007
768 COLD SWEAT 13 0.0007
769 PROTEINURIA 14 0.0007
770 HYPOAESTHESIA 110 0.0007
771 DRY SKIN 98 0.0007
772 DISORIENTATION 29 0.0007
773 SPINAL OPERATION 9 0.0007
774 POST PROCEDURAL COMPLICATION 14 0.0007
775 ARTHRALGIA 303 0.0007
776 DISEASE PROGRESSION 86 0.0007
777 PRESCRIBED OVERDOSE 14 0.0007
778 COAGULOPATHY 12 0.0007
779 HEPATOTOXICITY 16 0.0007
780 COORDINATION ABNORMAL 10 0.0007
781 HIP FRACTURE 23 0.0007
782 RASH PAPULAR 16 0.0007
783 LYMPHOMA 11 0.0007
784 HOT FLUSH 53 0.0007
785 OSTEONECROSIS 23 0.0007
786 CYANOSIS 11 0.0007
787 HYPERTHYROIDISM 10 0.0007
788 ABASIA 17 0.0007
789 TREATMENT FAILURE 57 0.0007
790 PLATELET COUNT DECREASED 73 0.0007
791 EYE PRURITUS 23 0.0007
792 FEELING COLD 19 0.0007
793 GASTROINTESTINAL HAEMORRHAGE 57 0.0007
794 CARDIAC ARREST 56 0.0007
795 SEROTONIN SYNDROME 13 0.0007
796 HALLUCINATION 51 0.0007
797 BACK DISORDER 11 0.0007
798 GLYCOSYLATED HAEMOGLOBIN INCREASED 17 0.0007
799 ERUCTATION 13 0.0007
800 PRODUCT PRESCRIBING ERROR 16 0.0007
801 LOSS OF CONSCIOUSNESS 86 0.0007
802 METASTASES TO BONE 11 0.0007
803 VISION BLURRED 92 0.0007
804 JAUNDICE 18 0.0007
805 PAIN OF SKIN 18 0.0007
806 SINUS CONGESTION 9 0.0007
807 DIABETIC KETOACIDOSIS 16 0.0007
808 GENERAL PHYSICAL HEALTH DETERIORATION 77 0.0007
809 HOSPITALISATION 102 0.0007
810 NEUTROPENIA 90 0.0007
811 CYTOMEGALOVIRUS INFECTION 11 0.0007
812 CEREBROVASCULAR ACCIDENT 112 0.0007
813 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
814 DIPLOPIA 17 0.0007
815 HIP ARTHROPLASTY 10 0.0007
816 UPPER LIMB FRACTURE 13 0.0007
817 NASOPHARYNGITIS 119 0.0006
818 DERMATITIS ATOPIC 34 0.0006
819 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
820 PARAESTHESIA 101 0.0006
821 BLOOD TEST ABNORMAL 9 0.0006
822 INTENTIONAL PRODUCT USE ISSUE 56 0.0006
823 SKIN REACTION 9 0.0006
824 PARANOIA 11 0.0006
825 MELAENA 14 0.0006
826 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
827 UNEVALUABLE EVENT 48 0.0006
828 FRACTURE 12 0.0006
829 BLOOD URINE PRESENT 12 0.0006
830 PNEUMOTHORAX 10 0.0006
831 TACHYCARDIA 56 0.0006
832 RESTLESSNESS 23 0.0006
833 WHITE BLOOD CELL COUNT DECREASED 68 0.0006
834 THERAPY NON-RESPONDER 28 0.0006
835 BRADYCARDIA 33 0.0006
836 CHOKING 12 0.0006
837 HYPERHIDROSIS 79 0.0006
838 EXTRAPYRAMIDAL DISORDER 15 0.0006
839 SKIN CANCER 13 0.0006
840 ALANINE AMINOTRANSFERASE INCREASED 37 0.0006
841 TARDIVE DYSKINESIA 17 0.0006
842 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
843 RESPIRATORY DISORDER 18 0.0006
844 HEPATIC ENZYME INCREASED 41 0.0006
845 SUICIDAL IDEATION 55 0.0006
846 COVID-19 105 0.0006
847 HEART RATE DECREASED 21 0.0006
848 METABOLIC ACIDOSIS 19 0.0006
849 VERTIGO 36 0.0006
850 THERAPY INTERRUPTED 42 0.0006
851 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
852 MUSCULOSKELETAL DISORDER 11 0.0006
853 INCREASED APPETITE 11 0.0006
854 DEMENTIA 16 0.0006
855 LOWER LIMB FRACTURE 11 0.0006
856 DEPRESSED MOOD 30 0.0006
857 SKIN DISCOLOURATION 26 0.0006
858 HEPATIC FAILURE 17 0.0006
859 LIVER FUNCTION TEST INCREASED 12 0.0006
860 PRODUCT DOSE OMISSION ISSUE 164 0.0006
861 SPEECH DISORDER 29 0.0006
862 ROAD TRAFFIC ACCIDENT 23 0.0005
863 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 99 0.0005
864 FULL BLOOD COUNT DECREASED 11 0.0005
865 ALOPECIA 107 0.0005
866 UNRESPONSIVE TO STIMULI 14 0.0005
867 PSYCHOTIC DISORDER 16 0.0005
868 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
869 EYE IRRITATION 31 0.0005
870 URTICARIA 90 0.0005
871 FEELING ABNORMAL 128 0.0005
872 PERITONITIS 11 0.0005
873 CONVULSION 30 0.0005
874 GASTRIC DISORDER 18 0.0005
875 CHOLESTASIS 10 0.0005
876 FEAR 14 0.0005
877 NIGHTMARE 18 0.0005
878 NERVOUSNESS 27 0.0005
879 FEMUR FRACTURE 16 0.0005
880 IMPAIRED WORK ABILITY 11 0.0005
881 MUSCULOSKELETAL STIFFNESS 45 0.0005
882 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
883 NERVOUS SYSTEM DISORDER 16 0.0005
884 BLOOD PRESSURE DECREASED 34 0.0005
885 HEAD DISCOMFORT 9 0.0005
886 LABORATORY TEST ABNORMAL 15 0.0005
887 ISCHAEMIC STROKE 9 0.0005
888 HEART RATE INCREASED 49 0.0005
889 NEOPLASM PROGRESSION 17 0.0005
890 ARRHYTHMIA 23 0.0005
891 VISUAL IMPAIRMENT 60 0.0005
892 EXPIRED PRODUCT ADMINISTERED 16 0.0005
893 CARDIAC DISORDER 45 0.0005
894 MEMORY IMPAIRMENT 66 0.0005
895 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
896 CARDIO-RESPIRATORY ARREST 20 0.0005
897 PALLOR 13 0.0005
898 MUSCLE TWITCHING 11 0.0005
899 KNEE ARTHROPLASTY 10 0.0005
900 DYSGEUSIA 35 0.0005
901 ANAPHYLACTIC REACTION 26 0.0005
902 RETCHING 10 0.0005
903 SEIZURE 54 0.0005
904 THERAPEUTIC RESPONSE DECREASED 28 0.0005
905 AMNESIA 30 0.0005
906 BLOOD GLUCOSE DECREASED 22 0.0005
907 FEELING HOT 28 0.0005
908 SURGERY 26 0.0004
909 DISEASE RECURRENCE 21 0.0004
910 INFLUENZA LIKE ILLNESS 36 0.0004
911 ADVERSE DRUG REACTION 39 0.0004
912 CARDIOVASCULAR DISORDER 11 0.0004
913 BLOOD GLUCOSE INCREASED 81 0.0004
914 HEPATIC FUNCTION ABNORMAL 16 0.0004
915 ANAPHYLACTIC SHOCK 11 0.0004
916 INFLAMMATION 22 0.0004
917 MYOCARDIAL INFARCTION 74 0.0004
918 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
919 TREATMENT NONCOMPLIANCE 23 0.0004
920 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
921 PRODUCT PRESCRIBING ISSUE 9 0.0004
922 DEATH 354 0.0004
923 MOOD SWINGS 13 0.0004
924 FLUSHING 41 0.0004
925 EYE DISORDER 13 0.0004
926 PRODUCT AVAILABILITY ISSUE 9 0.0004
927 SKIN IRRITATION 18 0.0004
928 INJECTION SITE RASH 12 0.0004
929 INJECTION SITE PRURITUS 26 0.0004
930 LIVER DISORDER 17 0.0004
931 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
932 AGITATION 28 0.0004
933 BLOOD PRESSURE FLUCTUATION 9 0.0004
934 NEOPLASM MALIGNANT 25 0.0004
935 LIVER INJURY 9 0.0004
936 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
937 VISUAL ACUITY REDUCED 12 0.0004
938 PANCREATITIS 19 0.0004
939 INJECTION SITE SWELLING 27 0.0004
940 THERAPY CESSATION 18 0.0004
941 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
942 PANCREATIC CARCINOMA 10 0.0003
943 APPLICATION SITE ERYTHEMA 9 0.0003
944 LACTIC ACIDOSIS 11 0.0003
945 MOOD ALTERED 9 0.0003
946 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
947 DRUG DOSE OMISSION 54 0.0003
948 ANGER 11 0.0003
949 PRODUCT QUALITY ISSUE 43 0.0003
950 DISTURBANCE IN ATTENTION 17 0.0003
951 COMA 15 0.0003
952 ABNORMAL BEHAVIOUR 12 0.0003
953 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
954 RHEUMATOID ARTHRITIS 34 0.0003
955 DRUG WITHDRAWAL SYNDROME 26 0.0003
956 ADVERSE EVENT 27 0.0003
957 MULTIPLE SCLEROSIS RELAPSE 20 0.0003
958 PRODUCT DOSE OMISSION 19 0.0003
959 WITHDRAWAL SYNDROME 12 0.0003
960 INJECTION SITE ERYTHEMA 35 0.0003
961 CEREBRAL HAEMORRHAGE 10 0.0003
962 DRUG EFFECT INCOMPLETE 10 0.0003
963 UNDERDOSE 20 0.0003
964 INJECTION SITE PAIN 78 0.0003
965 INCORRECT DOSE ADMINISTERED 58 0.0003
966 SKIN BURNING SENSATION 18 0.0003
967 MULTIPLE SCLEROSIS 12 0.0003
968 IRRITABILITY 15 0.0002
969 SUICIDE ATTEMPT 15 0.0002
970 INJECTION SITE REACTION 17 0.0002
971 BLINDNESS 10 0.0002
972 INJECTION SITE MASS 9 0.0002
973 ACNE 18 0.0002
974 NO ADVERSE EVENT 43 0.0002
975 DEVICE ISSUE 21 0.0002
976 PRODUCT SUBSTITUTION ISSUE 13 0.0002
977 INJECTION SITE BRUISING 18 0.0002
978 EXTRA DOSE ADMINISTERED 9 0.0002
979 TOXICITY TO VARIOUS AGENTS 37 0.0002
980 LUNG NEOPLASM MALIGNANT 9 0.0002
981 OVERDOSE 45 0.0002
982 INTERSTITIAL LUNG DISEASE 10 0.0002
983 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
984 INJECTION SITE HAEMORRHAGE 16 0.0002
985 AGGRESSION 10 0.0002
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
987 INTENTIONAL PRODUCT MISUSE 16 0.0002
988 BREAST CANCER 16 0.0002
989 DRUG DEPENDENCE 27 0.0002
990 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
991 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
992 PRODUCT STORAGE ERROR 10 0.0001
993 PROSTATE CANCER 9 0.0001